Screening

Molecular Devices introduces the FLIPR^® Penta system

2 August 2019 | By Molecular Devices

Molecular Devices, LLC, today announced the launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System.

Application note: Monitoring Aggregation of Antibody-Drug Conjugates

30 July 2019 | By Enzo Life Sciences

Prediction of Aggregation Propensity and Monitoring of Aggregation of Antibody-Drug Conjugates (ADC).

Encouraging drug discovery and therapeutic targets for dementia

26 July 2019 | By Victoria Rees (Drug Target Review)

A review has been published by experts in neurodegeneration research, detailing six ways to improve dementia research. This article investigates one of these suggestions, focusing on how we can improve drug target identification.

Screening identifies gene which protects cells from Zika virus

26 July 2019 | By Victoria Rees (Drug Target Review)

Researchers used screening to discover genes that protect the body against the Zika virus, which could inform potential therapies against the virus.

Chemical synthesis and biological screening combined on chip

16 July 2019 | By Victoria Rees (Drug Target Review)

Researchers have developed a chip which facilitates and accelerates active substance production, characterisation and biological effectiveness.

Intellicyt iQue3 – Faster, Smarter Flow Cytometry

8 July 2019 | By IntelliCyt Corporation

This advanced flow cytometry platform is a complete instrument, reagents and software solution streamlined to rapidly generate results not just data.

Titian Software Ltd

Video: Ethical and regulatory use of biospecimens in the EU

1 July 2019 | By BioIVT

Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.

Video: Multiplex IHC and digital analysis for immuno-oncology

1 July 2019 | By BioIVT

High content data derived for complex immuno-oncology research facilitates a deeper understanding of the tissue microenvironment.

Gene discovery could make cancer therapies more effective

25 June 2019 | By Victoria Rees (Drug Target Review)

A recent study has identified the DBC1 gene which leaves cancer cells more exposed to therapies.

Screening and beyond in drug discovery

14 June 2019 | By Sheraz Gul (Head of Drug Discovery at the Fraunhofer Institute for Molecular Biology and Applied Ecology)

Progressing drug discovery projects to a stage that attracts commercial interest is a challenging endeavour, evidenced by the fact that only a small proportion of drug discovery projects are successfully progressed to such a stage. A major cause of this is the lack of comprehensive profiling of compounds prior to…

First in vitro lung cancer test launched

12 June 2019 | By Victoria Rees (Drug Target Review)

A new in vitro lung cancer diagnostic test has been launched by Roche Diagnostics to provide improved detection of cancer.

Application note: Detection of anti-drug antibody (ADA) using single molecule counting (SMC^TM) technology

11 June 2019 | By Merck

All biological therapeutics have the potential to induce an immunemediated response ranging from benign to severe adverse effects.

Researchers identify chemotherapy-enhancing molecule

10 June 2019 | By Victoria Rees (Drug Target Review)

A new study has found a small molecule which prevents cancer cells from mutating and becoming resistant to chemotherapy.

Screening In-Depth Focus 2019

7 June 2019 | By Drug Target Review

This in-depth focus discusses screening and the uses of phenotypic profiling in drug discovery. Also examined is the role that CRISPR/Cas9 gene editing and native mass spectrometry play.